A team of scientists and technologists from Microsoft Research, Providence Health and the University of Washington has released a groundbreaking AI tool called GigaTIME designed to accelerate advanced tumor analysis and immune profiling. Traditionally, understanding the complex interactions between cancer cells and the immune system required multiplex immunofluorescence (mIF)  a laboratory process that can take days and cost hundreds to thousands of dollars per sample. GigaTIME uses machine learning to virtually generate comparable immune profiling data from standard pathology (H&E) slides in seconds, dramatically shortening timelines and slashing costs. 

Developed on massive datasets combining routine pathology images with detailed protein marker information, GigaTIME can simulate virtual spatial proteomics  digital maps of how immune cells and proteins interact within the tumor microenvironment. This capability unlocks new opportunities for researchers to conduct population-scale studies, explore treatment responsiveness and identify immune-related signatures tied to staging, survival and biomarker patterns across numerous cancer types and subtypes. By bypassing expensive lab assays, the tool makes advanced profiling accessible to many more labs and clinicians. 

The collaborators have published findings on GigaTIME in a peer-reviewed study and made the model openly accessible as a research resource, enabling scientists worldwide to explore tumor biology at unprecedented depth. The long-term vision includes using such computational insights to drive precision oncology  tailoring cancer therapies based on a patient’s specific tumor and immune landscape  and supporting discovery efforts that could lead to better treatment strategies, improved clinical outcomes and more efficient clinical trials.